The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anticoagulants-Global Market Insights and Sales Trends 2025
Synopsis
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulants market size is expected to reach US$ 35930 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulants in various end use industries. The expanding demands from the VTE, ACS/MI, AF and Others, are propelling Anticoagulants market. Platelet Aggregation Inhibitors (PAI), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low-Molecular-Weight Heparin (LMWH) segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulants covered in this report include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc.
The global Anticoagulants market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Global Anticoagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulants market, Segment by Type:
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Global Anticoagulants market, by Application
VTE
ACS/MI
AF
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulants market size is expected to reach US$ 35930 million by 2029, growing at a CAGR of 4.7% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulants in various end use industries. The expanding demands from the VTE, ACS/MI, AF and Others, are propelling Anticoagulants market. Platelet Aggregation Inhibitors (PAI), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Low-Molecular-Weight Heparin (LMWH) segment is estimated at % CAGR for the next seven-year period.
Market competition is intense. Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson, Genentech (Roche) and Boehringer Ingelheim etc. are the leaders of the industry, with about 64% market shares.
North America is the largest consumption place, with a consumption market share nearly 39%. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulants, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulants market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulants market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulants sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulants covered in this report include Sanofi, Bristol-Myers Squibb, Bayer, Johnson & Johnson., Genentech (Roche), Boehringer Ingelheim, Lilly, Daiichi Sankyo and Otsuka, etc.
The global Anticoagulants market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Bristol-Myers Squibb
Bayer
Johnson & Johnson.
Genentech (Roche)
Boehringer Ingelheim
Lilly
Daiichi Sankyo
Otsuka
AstraZeneca
Pfizer
Aspen
The Medicines Company
Global Anticoagulants market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulants market, Segment by Type:
Platelet Aggregation Inhibitors (PAI)
Low-Molecular-Weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Direct Factor Xa Inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Global Anticoagulants market, by Application
VTE
ACS/MI
AF
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anticoagulants companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anticoagulants
1.1 Anticoagulants Market Overview
1.1.1 Anticoagulants Product Scope
1.1.2 Anticoagulants Market Status and Outlook
1.2 Global Anticoagulants Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anticoagulants Market Size by Region (2018-2029)
1.4 Global Anticoagulants Historic Market Size by Region (2018-2023)
1.5 Global Anticoagulants Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anticoagulants Market Size (2018-2029)
1.6.1 North America Anticoagulants Market Size (2018-2029)
1.6.2 Europe Anticoagulants Market Size (2018-2029)
1.6.3 Asia-Pacific Anticoagulants Market Size (2018-2029)
1.6.4 Latin America Anticoagulants Market Size (2018-2029)
1.6.5 Middle East & Africa Anticoagulants Market Size (2018-2029)
2 Anticoagulants Market by Type
2.1 Introduction
2.1.1 Platelet Aggregation Inhibitors (PAI)
2.1.2 Low-Molecular-Weight Heparin (LMWH)
2.1.3 Direct Thrombin Inhibitor (DTI)
2.1.4 Direct Factor Xa Inhibitors (DFXa)
2.1.5 Vitamin K antagonists (VKA)
2.1.6 Others
2.2 Global Anticoagulants Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anticoagulants Historic Market Size by Type (2018-2023)
2.2.2 Global Anticoagulants Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anticoagulants Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anticoagulants Revenue Breakdown by Type (2018-2029)
3 Anticoagulants Market Overview by Application
3.1 Introduction
3.1.1 VTE
3.1.2 ACS/MI
3.1.3 AF
3.1.4 Others
3.2 Global Anticoagulants Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anticoagulants Historic Market Size by Application (2018-2023)
3.2.2 Global Anticoagulants Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anticoagulants Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anticoagulants Revenue Breakdown by Application (2018-2029)
4 Anticoagulants Competition Analysis by Players
4.1 Global Anticoagulants Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulants as of 2022)
4.3 Date of Key Players Enter into Anticoagulants Market
4.4 Global Top Players Anticoagulants Headquarters and Area Served
4.5 Key Players Anticoagulants Product Solution and Service
4.6 Competitive Status
4.6.1 Anticoagulants Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Anticoagulants Products, Services and Solutions
5.1.4 Sanofi Anticoagulants Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Profile
5.2.2 Bristol-Myers Squibb Main Business
5.2.3 Bristol-Myers Squibb Anticoagulants Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Anticoagulants Revenue (US$ Million) & (2018-2023)
5.2.5 Bristol-Myers Squibb Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Anticoagulants Products, Services and Solutions
5.3.4 Bayer Anticoagulants Revenue (US$ Million) & (2018-2023)
5.3.5 Johnson & Johnson. Recent Developments
5.4 Johnson & Johnson.
5.4.1 Johnson & Johnson. Profile
5.4.2 Johnson & Johnson. Main Business
5.4.3 Johnson & Johnson. Anticoagulants Products, Services and Solutions
5.4.4 Johnson & Johnson. Anticoagulants Revenue (US$ Million) & (2018-2023)
5.4.5 Johnson & Johnson. Recent Developments
5.5 Genentech (Roche)
5.5.1 Genentech (Roche) Profile
5.5.2 Genentech (Roche) Main Business
5.5.3 Genentech (Roche) Anticoagulants Products, Services and Solutions
5.5.4 Genentech (Roche) Anticoagulants Revenue (US$ Million) & (2018-2023)
5.5.5 Genentech (Roche) Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business
5.6.3 Boehringer Ingelheim Anticoagulants Products, Services and Solutions
5.6.4 Boehringer Ingelheim Anticoagulants Revenue (US$ Million) & (2018-2023)
5.6.5 Boehringer Ingelheim Recent Developments
5.7 Lilly
5.7.1 Lilly Profile
5.7.2 Lilly Main Business
5.7.3 Lilly Anticoagulants Products, Services and Solutions
5.7.4 Lilly Anticoagulants Revenue (US$ Million) & (2018-2023)
5.7.5 Lilly Recent Developments
5.8 Daiichi Sankyo
5.8.1 Daiichi Sankyo Profile
5.8.2 Daiichi Sankyo Main Business
5.8.3 Daiichi Sankyo Anticoagulants Products, Services and Solutions
5.8.4 Daiichi Sankyo Anticoagulants Revenue (US$ Million) & (2018-2023)
5.8.5 Daiichi Sankyo Recent Developments
5.9 Otsuka
5.9.1 Otsuka Profile
5.9.2 Otsuka Main Business
5.9.3 Otsuka Anticoagulants Products, Services and Solutions
5.9.4 Otsuka Anticoagulants Revenue (US$ Million) & (2018-2023)
5.9.5 Otsuka Recent Developments
5.10 AstraZeneca
5.10.1 AstraZeneca Profile
5.10.2 AstraZeneca Main Business
5.10.3 AstraZeneca Anticoagulants Products, Services and Solutions
5.10.4 AstraZeneca Anticoagulants Revenue (US$ Million) & (2018-2023)
5.10.5 AstraZeneca Recent Developments
5.11 Pfizer
5.11.1 Pfizer Profile
5.11.2 Pfizer Main Business
5.11.3 Pfizer Anticoagulants Products, Services and Solutions
5.11.4 Pfizer Anticoagulants Revenue (US$ Million) & (2018-2023)
5.11.5 Pfizer Recent Developments
5.12 Aspen
5.12.1 Aspen Profile
5.12.2 Aspen Main Business
5.12.3 Aspen Anticoagulants Products, Services and Solutions
5.12.4 Aspen Anticoagulants Revenue (US$ Million) & (2018-2023)
5.12.5 Aspen Recent Developments
5.13 The Medicines Company
5.13.1 The Medicines Company Profile
5.13.2 The Medicines Company Main Business
5.13.3 The Medicines Company Anticoagulants Products, Services and Solutions
5.13.4 The Medicines Company Anticoagulants Revenue (US$ Million) & (2018-2023)
5.13.5 The Medicines Company Recent Developments
6 North America
6.1 North America Anticoagulants Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anticoagulants Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulants Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anticoagulants Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulants Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anticoagulants Market Dynamics
11.1 Anticoagulants Industry Trends
11.2 Anticoagulants Market Drivers
11.3 Anticoagulants Market Challenges
11.4 Anticoagulants Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
